Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review, The Lancet, vol.372, issue.9651, 2008. ,
DOI : 10.1016/S0140-6736(08)61311-2
The epidemiology of viral hepatitis among people who inject drugs: Results of global systematic reviews, Lancet, 2011. ,
Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience. Drug Alcohol Depend, 2009. ,
Global estimates of prevalence of HCV infection among injecting drug users, International Journal of Drug Policy, vol.18, issue.5, 2007. ,
DOI : 10.1016/j.drugpo.2007.04.004
HIV and hepatitis C virus co-infection, Lancet Infect Dis, 2004. ,
Estimation de la séroprévalence du VIH et de l'hépatite C chez les usagers de drogues en France ? premiers résultats de l'enquête ANRS- COQUELICOT, pp.39-40, 2011. ,
Recommandations pour la prise en charge de l'infection par le virus de ,
Addicts with chronic hepatitis C: Difficult to reach, manage or treat? World Journal of gastro-enterology, 2013. ,
Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece, European Journal of Gastroenterology & Hepatology, vol.25, issue.5, 2013. ,
DOI : 10.1097/MEG.0b013e32835cb5c0
Etat des lieux de la prise en charge de l'hépatite C chronique chez les patients migrants en situation de précarité au centre hospitalier de Chambéry. Human health and pathology, 2014. ,
Reasons for HCV non-treatment in underserved African Americans: Implications for treatment with new therapeutics, Ann. Hepatol, 2015. ,
Elbasvir???Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy, Annals of Internal Medicine, 2016. ,
DOI : 10.7326/M16-0816
The PREVAIL Study: intensive models of HCV care for people who inject drugs, Journal of Hepatology, vol.66, issue.1, 2017. ,
DOI : 10.1016/S0168-8278(17)30406-3
Intravenous Drug Users Can Achieve a High Sustained Virological Response Rate: experience From Croatian Reference Center for Viral Hepatitis. Hepatitis monthly, 2011. ,
DOI : 10.5812/kowsar.1735143x.779
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282032/pdf
Hepatitis patients lost to follow-up at a liver centre in a tertiary care hospital of Karachi, Pakistan ? a cross-sectional descriptive study, 2013. ,
Les patients perdus de vue en région Haute Normandie en 2013, COREVIH Haute Normandie ,
How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalit?? 2000 survey and death certificates, HIV Medicine, vol.10, issue.4, 2009. ,
DOI : 10.1111/j.1468-1293.2008.00678.x
Description du profil des sujets diagnostiqués séropositifs pour le VIH et de leur devenir durant la première année suivant le diagnostic dans l'Ouest Guyanais en Guyane, 2014. ,
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00182959
Barriers to Hepatitis C Virus Treatment in a Canadian HIV-Hepatitis C Virus Coinfection Tertiary Care Clinic, Canadian Journal of Gastroenterology, vol.22, issue.2, 2008. ,
DOI : 10.1155/2008/949582
The physician?patient working alliance. Patient education and counselling, 2007. ,
DOI : 10.1016/j.pec.2006.09.013
L'entretien motivationnel, aider la personne à engager le changement ,
Représentations du traitement de l'hépatite C chez les usagers de drogues, Enquête InVS-ANRS Coquelicot, 2004. ,
Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern, BMC Public Health, vol.106, issue.11, 2015. ,
DOI : 10.1111/j.1360-0443.2011.03515.x
URL : https://hal.archives-ouvertes.fr/inserm-01264470
Prevalence of human immunodeficiency virus and hepatitis C virus 53, 2004. ,
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users, Addiction, vol.361, issue.9, 2007. ,
DOI : 10.1111/j.1360-0443.2007.01912.x
Assessment and management of HCV infection. It's your liver: peer to peer HCV testing and education, 2016. ,
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel, Liver International, vol.86, issue.(S, 2011. ,
DOI : 10.1053/j.gastro.2009.02.006
Epidemiology & importance of monitoring. EASL-The International Liver Congress 2014, 49th Annual Meeting of the European Association for the Study of the Liver, 2014. ,
Prévalence de la fibrose hépatique chez les usagers de drogues fréquentant les Caarud et Csapa d'Île-de-France ,
Un parcours de santé " bas seuil " pour atteindre le foyer viral de l'hépatite C. Le courrier des addictions, 2016. ,
Significant reductions in costs of generic production of sofosbuvir and ,
Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs, Hepatology, vol.8, issue.Suppl 1, 2016. ,
DOI : 10.1371/journal.pone.0078286
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013, The Lancet Infectious Diseases, vol.16, issue.12, 2016. ,
DOI : 10.1016/S1473-3099(16)30325-5
Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial, Clinical Infectious Diseases, vol.57, issue.suppl_2 ,
DOI : 10.1093/cid/cit307
URL : https://academic.oup.com/cid/article-pdf/57/suppl_2/S97/20912419/cit307.pdf
Texte pour l'appel du médecin traitant Au secrétariat : Bonjour, je suis Hélène Van Elslande ,
Je fais ma thèse sur les patients perdus de vue de l'hépatite C ,